R. Gonzalez

630 total citations
43 papers, 459 citations indexed

About

R. Gonzalez is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, R. Gonzalez has authored 43 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Surgery. Recurrent topics in R. Gonzalez's work include Melanoma and MAPK Pathways (10 papers), CAR-T cell therapy research (7 papers) and Cutaneous Melanoma Detection and Management (6 papers). R. Gonzalez is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), CAR-T cell therapy research (7 papers) and Cutaneous Melanoma Detection and Management (6 papers). R. Gonzalez collaborates with scholars based in Chile, United States and Australia. R. Gonzalez's co-authors include Peter Hersey, Andrew S. Kraft, Grant A. McArthur, Igor Puzanov, Anne C. Pavlick, Steven O’Day, E. M. Hersh, A. Ribas, K. B. Nolop and Lynn M. Schuchter and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

R. Gonzalez

39 papers receiving 443 citations

Peers

R. Gonzalez
Graziela Zibetti Dal Molin Brazil
Jessica Boklan United States
Samantha Bowyer Australia
Helen Gharwan United States
Kenji Kido Japan
Weiwei Shi China
Hey-Chi Hsu Taiwan
Steven W. Remmenga United States
Danae Hamouda United States
Julie A. Di Paolo United States
Graziela Zibetti Dal Molin Brazil
R. Gonzalez
Citations per year, relative to R. Gonzalez R. Gonzalez (= 1×) peers Graziela Zibetti Dal Molin

Countries citing papers authored by R. Gonzalez

Since Specialization
Citations

This map shows the geographic impact of R. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Gonzalez more than expected).

Fields of papers citing papers by R. Gonzalez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Gonzalez. The network helps show where R. Gonzalez may publish in the future.

Co-authorship network of co-authors of R. Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of R. Gonzalez. A scholar is included among the top collaborators of R. Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Gonzalez. R. Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tarhini, Ahmad A., Zeynep Eroglu, Jonathan S. Zager, et al.. (2024). Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma. Clinical Cancer Research. 30(23). 5333–5341. 4 indexed citations
3.
Garrido‐Olivares, Luis, et al.. (2023). Case report: Multi-site perfusion strategy for type A acute aortic dissection complicated with cerebral malperfusion. Frontiers in Cardiovascular Medicine. 10. 1124181–1124181. 1 indexed citations
4.
Gonzalez, R., et al.. (2020). Initial Experience in Chile with Stent Implantation in the Right Ventricle Outflow Tract in High-Risk Patients with Tetralogy of Fallot. Pediatric Cardiology. 41(4). 837–842. 7 indexed citations
5.
Becker, Pedro, et al.. (2017). Resultados de un programa nacional de trasplante cardiaco pediátrico: fortalezas y debilidades. Revista chilena de pediatría. 88(3). 367–376.
6.
Becker, Pedro, et al.. (2016). Infección del sitio quirúrgico en niños sometidos a cirugía cardíaca con cierre esternal diferido: Estudio de casos y controles. Revista chilena de infectología. 33(5). 495–500. 2 indexed citations
7.
Gonzalez, R., Michelle A. Lane, Nikki J. Wagner, et al.. (2015). PLoS Pathogens Issue Image | Vol. 11(1) January 2015. PLoS Pathogens. 11(1). ev11.i01–ev11.i01.
8.
Urcelay, Gonzalo, et al.. (2015). Síndrome de hipoplasia de corazón izquierdo: experiencia de 10 años de un programa de etapificación quirúrgica. Revista chilena de pediatría. 87(2). 121–128. 1 indexed citations
9.
Lewis, Karl D., A. Ribas, R. Gonzalez, et al.. (2015). 3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial. European Journal of Cancer. 51. S679–S679. 2 indexed citations
10.
Yan, Y., Grant A. McArthur, Thomas F. Gajewski, et al.. (2014). Vemurafenib and Cobimetinib Potently Inhibit Ps6 Signaling in Brafv600 Mutation–Positive Locally Advanced or Metastatic Melanoma from Brim7 Study. Annals of Oncology. 25. iv378–iv378. 2 indexed citations
11.
Catalán, Diego, Octavio Aravena, Roberto Ariel Abeldaño Zúñiga, et al.. (2011). Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles. Rheumatology International. 32(6). 1819–1825. 6 indexed citations
12.
Domínguez, José Ignacio Barranco, et al.. (2009). Factors That Predict Duration of Delayed Graft Function in Cadaveric Kidney Transplantation. Transplantation Proceedings. 41(6). 2668–2669. 14 indexed citations
13.
Samlowski, Wolfram E., Jeffrey S. Weber, R. Gonzalez, et al.. (2008). Phase I/II study of imexon (AMP) plus dacarbazine (DTIC) in patients (Pts) with metastatic malignant melanoma. Journal of Clinical Oncology. 26(15_suppl). 9066–9066. 1 indexed citations
14.
Domínguez, José Ignacio Barranco, Rolando Rebolledo, P. Troncoso, et al.. (2008). DURATION OF DELAYED GRAFT FUNCTION IS AN IMPORTANT PREDICTOR OF ONE YEAR SERUM CREATININE. Transplantation. 86(2S). 471–471. 1 indexed citations
15.
Gonzalez, R., Karl D. Lewis, Wolfram E. Samlowski, et al.. (2007). A phase II study of YM155, a novel survivin suppressant, administered by 168 hour continuous infusion in patients with unresectable stage III or stage IV melanoma. Journal of Clinical Oncology. 25(18_suppl). 8538–8538. 6 indexed citations
16.
Legha, S S, R. Gonzalez, Colin R. Anderson, et al.. (2006). A phase III randomized trial of adjuvant biochemotherapy (BC) versus interferon-α-2b (IFN) in patients (pts) with high risk for melanoma recurrence. Journal of Clinical Oncology. 24(18_suppl). 8003–8003. 2 indexed citations
17.
Gonzalez, R., et al.. (2003). Metodo de evaluación cualitativa de impactos ambientales: una propuesta. Dialnet (Universidad de la Rioja). 12(1). 79–92. 3 indexed citations
18.
Gonzalez, R., et al.. (1999). Treatment of patients with metastatic melanoma with bryostatin-1 - phase II study. Melanoma Research. 9(6). 599–606. 38 indexed citations
19.
Feun, Lynn G., et al.. (1995). Phase II Trial of Piritrexim and DTIC Using an Alternating Dose Schedule in Metastatic Melanoma. American Journal of Clinical Oncology. 18(6). 488–490. 6 indexed citations
20.
Aparicio, M., H. Gin, L. Potaux, et al.. (1988). Effect of a Low-Protein Diet on Urinary Albumin Excretion in Uremic Patients. ˜The œNephron journals/Nephron journals. 50(4). 288–291. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graziela Zibetti Dal Molin Breakdown of academic impact, for papers by Jessica Boklan Breakdown of academic impact, for papers by Samantha Bowyer Breakdown of academic impact, for papers by Helen Gharwan Breakdown of academic impact, for papers by Kenji Kido Breakdown of academic impact, for papers by Weiwei Shi Breakdown of academic impact, for papers by Hey-Chi Hsu Breakdown of academic impact, for papers by Steven W. Remmenga Breakdown of academic impact, for papers by Danae Hamouda Breakdown of academic impact, for papers by Julie A. Di Paolo
Rankless by CCL
2026